The immunosuppressant rapamycin interferes with G(1)-phase progression
in lymphoid and other cell types by inhibiting the function; of the m
ammalian target of rapamycin (mTOR), mTOR was determined to be a termi
nal kinase in a signaling pathway that couples mitogenic stimulation t
o the phosphorylation of the eukaryotic initiation factor (eIF)-4E-bin
ding protein, PHAS-I. The rapamycin-sensitive protein kinase activity
of mTOR was required for phosphorylation of PHAS-I in insulin-stimulat
ed human embryonic kidney cells. mTOR phosphorylated PHAS-I on serine
and threonine residues in vitro, and these modifications inhibited the
binding of PHAS-I to eIF-4E. These studies define a role for mTOR in
translational control and offer further insights into the mechanism wh
ereby rapamycin inhibits G(1)-phase progression in mammalian cells.